Originally found in glioblastomas, PTEN K13E was the first lysine 13 mutation discovered and, like K289E, was also implicated in subcellular localization changes-shifts in PTEN protein away from the plasma membrane and out of the nucleus although this mutation is not seen in PHTS patients [22,55,89]. Here, PTEN is linked to PTEN hamartoma tumor syndrome.